MedTrace Logo

Enhanced SUPport for Initiation and paRticipation in a FOOD is Medicine Program

NCT06500962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2026-02-05

No results posted yet for this study

Summary

The purpose of this research is to see if offering more navigation and text-message support will help increase participation and engagement in a Food is Medicine program. The study will recruit people currently participating in cardiac rehabilitation. People will be randomly assigned to 1 of 4 study groups: navigation, text-messaging, both, or neither. People will complete surveys at the start of the study and after 3 months. After 3 months, we will compare how many Food is Medicine meals or groceries people in each group received.

Conditions

  • Cardiac Rehabilitation
  • Nutrition, Healthy
  • Nutrition Poor

Interventions

BEHAVIORAL

Usual Care

Participants will receive a message sent to their electronic health record portal with instructions about how to sign up for a food is medicine program.

BEHAVIORAL

Navigation

Participants will receive a weekly phone call from a navigator to promote enrollment in the food is medicine program and address any barriers to participation.

BEHAVIORAL

Text Messaging

Participants will receive two text messages per week to promote healthy eating, enrolling in a food is medicine program, and continuing to participate in a food is medicine program.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-12
Primary Completion
2026-01-07
Completion
2026-01-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06500962 on ClinicalTrials.gov